INTERNAL Research Analyst to Associate Consultant Application
Share
Job Location:
Monthly Salary:
Posted on:
10 hours ago
Vacancies:
1 Vacancy
Job Summary
Internal Opportunity for Transfer from Research Analyst to Associate Consultant
Requirements
-Have been in RA role for 12 months.
- Have a mastered rating at latest PDR
Benefits
Standard CHR benefits.
With an opportunity to work in a truly hybrid working environment we offer a flexible and supportive atmosphere as well as a competitive salary and benefits package that includes:
- 25 days holiday per year (with an additional day per year of service up to 30 days) plus all bank/public holidays and Christmas/New Year closure
- Contributory pension scheme
- Private health insurance
- Employee assistance programme
- Mind & Body allowance to support activities that proactively support your health & wellbeing (such as gym membership or wellbeing apps)
- Annual bonus
- Cycle to work scheme
- Flexible including hybrid working
- Life assurance
Right to Work and Visa Sponsorship
CHRs ability to make you an offer of employment is subject to the prevailing UK immigration rules. Under those rules visa sponsorship for this position is currently only available for applicants who meet the UK governments criteria for a New Entrant Skilled Worker visa applicant (which are subject to change by the UK government at any time). However if you do require sponsorship we will only consider your application if we have any available Certificates of Sponsorship at the time of your application.
CHR is an Equal Opportunity Employer and makes all employment decisions objectively on merit without regard to age national origin race ethnicity religion creed gender sexual orientation disability veteran status or any other characteristic protected by law.
Required Experience:
IC
About Company
Cambridge Healthcare Research (CHR) provides strategic decision support and action planning to a wide range of stakeholders in the life-science and healthcare space. Working closely with our clients, CHR translates evolving treatment algorithms, patient pathways and novel technologies ... View more
